These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2045455)

  • 1. Scaling up in isolation of medium-size uraemic toxins.
    Gallice PM; Crevat AD; Berland YF
    J Chromatogr; 1991 Feb; 539(2):449-53. PubMed ID: 2045455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation, isolation, and identification of middle molecules.
    Bergström J; Fürst P; Zimmerman L
    Artif Organs; 1981; 4 Suppl():5-7. PubMed ID: 7295096
    [No Abstract]   [Full Text] [Related]  

  • 4. Uremic middle molecules: separation and quantitation.
    Chapman GV; Farrell PC
    Artif Organs; 1981; 4 Suppl():160-5. PubMed ID: 7295084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of conventional and high-performance liquid chromatographic techniques for the isolation of so-called "uraemic toxins".
    Brunner H; Mann H
    J Chromatogr; 1984 Aug; 297():405-16. PubMed ID: 6490772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Middle molecules" as nonspecific regulators of phagocyte activity].
    Volchegorskiĭ IA; Vlasov AV; Livshits GE; Akhkiamov EM; Skobeleva NA; Lifshits RI; Ebert LIa
    Biull Eksp Biol Med; 1995 Feb; 119(2):159-62. PubMed ID: 7670039
    [No Abstract]   [Full Text] [Related]  

  • 7. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P; Monti JP; Crevat A; Durand C; Murisasco A
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology for identification of serum middle molecules.
    Buzio C; Montagna G; Calderini C; Manari A; Migone L
    Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genesis of the uraemic syndrome: role of uraemic toxins.
    Hörl WH
    Wien Klin Wochenschr; 1998 Aug; 110(15):511-20. PubMed ID: 9782569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ultimate salt war? Uraemic toxins are all that count in dialysis patients.
    Vanholder R
    Nephrol Dial Transplant; 2012 Jan; 27(1):62-6. PubMed ID: 22287703
    [No Abstract]   [Full Text] [Related]  

  • 11. Separation, isolation and amino acid composition of uremic peptides.
    Shaykh M; Dubin A; Dunea G; Mamdani B; Ahmed S
    Clin Physiol Biochem; 1984; 2(1):1-13. PubMed ID: 6488692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of middle molecular substances in rat tissues: in vitro study.
    Dzúrik R; Cernácek P; Spustová V; Válek A
    Proc Eur Dial Transplant Assoc; 1978; 15():633-5. PubMed ID: 740703
    [No Abstract]   [Full Text] [Related]  

  • 13. Uremic toxins and the elusive middle molecules.
    Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
    Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
    [No Abstract]   [Full Text] [Related]  

  • 14. Uraemic toxins of high molecular weight inhibiting human mononuclear phagocytes cultured in vitro.
    Jörstad S; Kvernes S
    Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):221-6. PubMed ID: 362814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of chromatographically pure toxin of Clostridium botulinum type B.
    DasGupta BR; Boroff DA; Cheong K
    Biochem Biophys Res Commun; 1968 Sep; 32(6):1057-63. PubMed ID: 4882877
    [No Abstract]   [Full Text] [Related]  

  • 16. Analytical study for separation of middle molecules.
    Saito A; Kanazawa I; Chung TG; Maeda K
    Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of Clostridium botulinum type A toxin.
    Dasgupta BR; Berry LJ; Boroff DA
    Biochim Biophys Acta; 1970 Aug; 214(2):343-9. PubMed ID: 4993506
    [No Abstract]   [Full Text] [Related]  

  • 18. Chromatographic purification of the toxin of type E Clostridium botulinum.
    Emodi AS; Lechowich RV
    Biochem Biophys Res Commun; 1969 Jun; 35(6):788-95. PubMed ID: 4893076
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbohydrate content of middle molecular weight substances (MMWS) in uraemic patients: preliminary results.
    Le Moel G; Strecker G; Troupel S; Dolegeal M; Jacobs C; Galli A; Agneray J
    Artif Organs; 1981; 4 Suppl():37-40. PubMed ID: 7295093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of the principal neurotoxins of two Naja naja subspecies.
    Karlsson E; Arnberg H; Eaker D
    Eur J Biochem; 1971 Jul; 21(1):1-16. PubMed ID: 5568672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.